NIH-funded research Career grant

Exploring how skin bacteria can improve immune responses

Official title: Probing and engineering the B cell response to the skin microbiota

Funded at Stanford University · NIH-10985772 · Data updated 2026-11-12

This study is looking at how the good bacteria on our skin can help boost our immune system to fight infections better, with the goal of creating easier-to-use vaccines that could help people stay healthy without needing regular shots.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$131,085
NIH project number1K99AI180358-01A1
Project IDNIH-10985772 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are interested in improving their immune response to infections, particularly those who may benefit from mucosal vaccines.

Less likely to help

Patients who are not affected by bacterial infections or do not have a need for enhanced mucosal immunity may not benefit from this research.

What this research studies

This research investigates how the bacteria that naturally live on our skin can enhance the immune system's ability to respond to infections. By understanding the relationship between these bacteria and our immune cells, particularly B cells, the project aims to develop a new type of vaccine that works effectively at the site of infection. This approach could lead to vaccines that are easier to distribute and use, especially in areas with limited resources. Patients may benefit from improved immunity against infections without the need for traditional injections.

Why it matters

Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against infections at mucosal surfaces.

How similar studies have gone: Other research has shown promise in using microbiota to enhance immune responses, suggesting that this approach could be a viable and innovative strategy.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Bousbaine, Djenet — Stanford University
  • Study coordinator: Bousbaine, Djenet

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.